Coy Heldermon, MD, PhD

Where You Are:
Coy Heldermon, MD, PhD

Office  (352) 273-7497

Education And Training
  • Fellow, Washington University in St. Louis, 2008 - Hematology/Oncology
  • Resident, Barnes Jewish Hospital, 2004 - Internal Medicine
  • Intern, Stanford Hospital, 2002 - Obstetrics & Gynecology
  • MD, University of Oklahoma, 2001
  • PhD, University of Oklahoma Health Sciences Center, 1999 - Biochemistry & Molecular Biology Medicine


  • Ai L, Kim WJ, Alpay M, Tang M, Pardo CE, Hatakeyama S, May WS, Kladde MP, Heldermon CD, Siegel EM, Brown KD. TRIM29 suppresses TWIST1 and invasive breast cancer behavior. Cancer Res. 2014 Jun. Pubmedid: 24950909.
  • Kolarich AR, Reynolds BA, Heldermon CD. Ado-trastuzamab emtansine associated hyponatremia and intracranial hemorrhage. Acta Oncol. 2014 May;1-3. Pubmedid: 24834794.
TOOLS:   Font Size small font resizer separator font resizer separator big font resizer